HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Dana Cramariuc Selected Research

Simvastatin (Zocor)

1/2021Low myocardial energetic efficiency is associated with increased mortality in aortic stenosis.
1/2021Higher Acceleration/Ejection Time Ratio Predicts Impaired Outcome in Aortic Valve Stenosis.
1/2021Prognostic impact of impaired left ventricular midwall function during progression of aortic stenosis.
10/2019Low systemic arterial compliance is associated with increased cardiovascular morbidity and mortality in aortic valve stenosis.
1/2019Impact of Obesity on Persistent Left Ventricular Hypertrophy After Aortic Valve Replacement for Aortic Stenosis.
10/2017Echocardiographic aortic valve calcification and outcomes in women and men with aortic stenosis.
4/2017Comparison of Frequency of Ischemic Cardiovascular Events in Patients With Aortic Stenosis With Versus Without Asymmetric Septal Hypertrophy (from the SEAS Trial).
4/2017Small aortic root in aortic valve stenosis: clinical characteristics and prognostic implications.
11/2015Relation of Left Ventricular Mass to Prognosis in Initially Asymptomatic Mild to Moderate Aortic Valve Stenosis.
2/2015Sex differences in cardiovascular outcome during progression of aortic valve stenosis.
For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Dana Cramariuc Research Topics

Disease

27Aortic Valve Stenosis (Aortic Stenosis)
01/2021 - 02/2008
6Hypertension (High Blood Pressure)
01/2021 - 06/2006
3Stroke (Strokes)
02/2015 - 11/2008
3Obesity
05/2014 - 05/2010
2Morbid Obesity
04/2022 - 01/2021
2Heart Failure
03/2013 - 10/2012
2Myocardial Infarction
10/2012 - 11/2008
2Hypertrophy
11/2008 - 04/2008
1Atherosclerosis
04/2022
1Myocarditis (Carditis)
01/2021
1COVID-19
01/2021
1Heart Diseases (Heart Disease)
01/2021
1Overweight
10/2013
1Unstable Angina
10/2012
1Left Ventricular Hypertrophy (Ventricular Hypertrophy, Left)
04/2008

Drug/Important Bio-Agent (IBA)

26Simvastatin (Zocor)FDA LinkGeneric
01/2021 - 02/2008
25Ezetimibe (Zetia)FDA Link
01/2021 - 02/2008
2Losartan (Cozaar)FDA LinkGeneric
11/2008 - 04/2008
2Atenolol (Tenormin)FDA LinkGeneric
11/2008 - 04/2008
1Oxygen (Dioxygen)IBA
01/2021
1C-Reactive ProteinIBA
10/2017
1A 17 (A-17)IBA
10/2013
1Investigational DrugsIBA
04/2009
1Antihypertensive Agents (Antihypertensives)IBA
04/2008

Therapy/Procedure

2Bariatric Surgery
04/2022 - 01/2021
2Coronary Artery Bypass (Coronary Artery Bypass Surgery)
02/2015 - 10/2012
1Critical Care (Surgical Intensive Care)
01/2021
1Gastric Bypass (Roux-en-Y Gastric Bypass)
01/2021
1Length of Stay
10/2013
1Percutaneous Coronary Intervention
10/2012
1Transcatheter Aortic Valve Replacement
08/2011
1Prostheses and Implants (Prosthesis)
06/2006